2012 Congress

Viral Hepatitis Congress 2012
Johann Wolfgang Goethe-Universität, Frankfurt, Germany
7–9 September 2012

Scientific Programme*
Webcast
Posters
Abstracts*

* Opens in new window

Webcast

Accessing the webcast on a PC
Click the link [PC]

Recommended specifications to avoid play back issues:
Internet Explorer 7 or above
Screen resolution of 1024 x 768 or higher
Internet bandwidth of 750 kbps or higher

Accessing the webcast on a Mac
Click the link [MAC]

Recommended specifications to avoid play back issues:
Mac OS X 10.4.8 or later
Safari 2.0.4 or later
Screen resolution of 1024 x 768 or higher
Internet bandwidth of 750 kbps or higher

To view the slides from the presentations
Click the link [Slides]

All presentations open in a new window.


Friday 7 September 2012

Official Opening
Ira Jacobson (USA), Stefan Zeuzem (Germany)
[PC] [MAC] [Slides – part 1] [Slides – part 2]

Keynote Lectures

Hepatitis C virus
Ralf Bartenschlager (Germany)
[PC] [MAC] [Slides]

Hepatitis B virus
Brian J McMahon (USA)
[PC] [MAC] [Slides]


Saturday 8 September 2012

Management of HCV in the DAA Era

Previously treated patients: therapeutic considerations
Nezam Afdhal (USA)
[PC] [MAC] [Slides]

Side effect management: practical guidelines
Marc Bourlière (France)
[PC] [MAC] [Slides]

Resistance: what you need to know and why
Jean-Michel Pawlotsky (France)
[PC] [MAC] [Slides]

Oral Paper
Structure constraints related to HCV fitness deficits in the selection of resistant amino acid variants in the NS3 protease
Christoph Welsch (Germany)
[PC] [MAC]

Panel discussion and Q&A
[PC] [MAC]

Drug Interactions

Drug interactions: a pathophysiological review
David Back (UK)
[PC] [MAC] [Slides]

Clinical management of drug interactions in HCV: case study session
Antonio Craxì (Italy), Xavier Forns (Spain), Heiner Wedemeyer (Germany)
[PC] [MAC] [Slides – Part 1] [Slides – part 2] [Slides – part 3]

Overview of Therapies in Development for HCV

Host-targeting molecules: new interferons and cyclophilin inhibitors
Graham R Foster (UK)
[PC] [MAC]

New protease inhibitors and NS5A inhibitors with interferon
Mark Sulkowski (USA)
[PC] [MAC] [Slides]

Panel discussion and Q&A
[PC] [MAC]

Interferon-free regimens
David Nelson (USA)
[PC] [MAC] [Slides]

Quadruple regimens: are they realistic? For whom would they apply?
Jordan Feld (Canada)
[PC] [MAC] [Slides]

Panel discussion and Q&A
[PC] [MAC]

New Techniques for Diagnosis and Monitoring

Pathophysiological background and clinical applications of IL28B
Lars Martin Lagging (Sweden)
[PC] [MAC] [Slides]

Metabolic liver disease in patients with viral hepatitis
Francesco Negro (Switzerland)
[PC] [MAC] [Slides]

Non-invasive liver assessment
Laurent Castera (France)
[PC] [MAC]

Oral Paper
Persisting neurocognitive effects of INF/RBV
Igor Grant (USA)
[PC] [MAC]

Panel discussion and Q&A
[PC] [MAC]


Sunday 9 September 2012

Practical Management of Hepatitis B in 2012 (Part 1)

Starting with nucs
Pietro Lampertico (Italy)
[PC] [MAC] [Slides]

What is the role of interferon in 2012?
Patrick Marcellin (France)
[PC] [MAC] [Slides]

Treatment of hepatitis D
Michael P Manns (Germany)
[PC] [MAC]

Practical Management of Hepatitis B in 2012 (Part 2)

Review of combination studies in hepatitis B
Joerg Petersen (Germany)
[PC] [MAC]

Addressing unmet needs in hepatitis B treatment
Harry Janssen (The Netherlands)
[PC] [MAC] [Slides]

Oral Paper
A 2-year analysis of chronic hepatitis B management in five European countries: treatment initiation factors and the impact of healthcare policies
Krzysztof Simon (Poland)
[PC] [MAC] [Slides]

Oral Paper
Quantification of HBsAg in nucleos(t)ide-naïve patients treated for chronic hepatitis B with entecavir or entecavir plus tenofovir in the BE-LOW study
Jamie Griffin (France)
[PC] [MAC] [Slides]

HIV Co-infection and Transplantation

Managing viral hepatitis and HIV co-infection in 2012
Jürgen Rockstroh (Germany)
[PC] [MAC] [Slides]

Therapy of decompensated cirrhosis: pre-transplant for HBV and HCV
Thomas Berg (Germany)
[PC] [MAC] [Slides]

Focus on transplantation: treatment post-transplant for HBV and HCV
Christoph Sarrazin (Germany)
[PC] [MAC] [Slides]

Therapy of patients with end-stage renal disease for HBV and HCV
Paul Martin (USA)
[PC] [MAC] [Slides – Part 1] [Slides – Part 2]

New Advances in Managing Patients with HCC and Viral Hepatitis

Interventional and surgical treatment of HCC
Wolf Otto Bechstein (Germany)
[PC] [MAC] [Slides]

Oral Paper
Global miRNA expression profiling of laser-microdissected HCC tissue reveals distinct miRNA-patterns in four distinct sub-compartments within the tumour-infiltrated liver of HCV+ patients
Jan Peveling-Oberhag (Germany)
[PC] [MAC]

Medical treatment of HCC
Massimo G Colombo (Italy)
[PC] [MAC] [Slides]

Closing Remarks
Stefan Zeuzem (Germany)
[PC] [MAC]

Posters

Poster presentations are available as interactive books, these are separated into topics. Click the link [BOOK] for the interactive book, with turning pages (requires Adobe Flash Player).

Hepatitis C Virus
– Diagnosis
[BOOK]

Hepatitis C Virus
– Natural history and epidemiology
[BOOK]

Hepatitis C Virus
– Treatment and late-stage clinical trials (Phase IIb, Phase III and Phase IV)
– Practical management strategies
[BOOK]

Hepatitis C Virus
– Treatment monitoring and predictors of therapeutic response
[BOOK]

Hepatitis C Virus
– Other
[BOOK]

Hepatitis B Virus
– Diagnosis and monitoring
[BOOK]

Hepatitis B Virus
– Natural history and epidemiology
[BOOK]

Hepatitis B Virus
– Treatment and late-stage clinical trials (Phase IIb, Phase III and Phase IV)
– Practical management strategies
– Preclinical and early clinical development
[BOOK]

Hepatitis B Virus
– Other
Other
– HIV co-infection and viral hepatitis
[BOOK]